Synthesis and in vivo anticonvulsant evaluation of 2-chloroquinolinyl hydrazone derivatives

Acta Poloniae Pharmaceutica - Drug Research

Volumn 67, Issue 5, 2010, Pages 567-573

  Kumar, Suresh ^a   Bawa, Sandhya ^a   Drabu, Sushma ^a   Kumar, Rajiv ^a   Machawal, Lalit ^b  

^a HAMDARD UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

2 chloroquinoline; Anticonvulsant activity and neurotoxicity screening; Hydrazones

Indexed keywords

2 (4 CHLOROPHENYL) N' [(2 CHLOROQUINOLIN 3YL) METHYLIDENE]ACETOHYDRAZIDE; 2 CHLOROQUINOLINYL HYDRAZONE; 2 [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE]HYDRAZINECARBOTHIOAMIDE; 2 [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE]HYDRAZINECARBOXAMIDE; 2,4 DICHLORO N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE]BENZOHYDRAZIDE; 4 BROMO N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE]BENZOHYDRAZIDE; 4 CHLORO N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE]BENZOHYDRAZIDE; HYDRAZONE DERIVATIVE; N' (2 CHLOROQUINOLIN 3 YL)METHYLIDENE] 4 METHYLBENZOHYDRAZIDE; N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE] 2 PHENOXYACETOHYDRAZIDE; N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE] 2 PHENYLACETOHYDRAZIDE; N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE] 3METHYLBENZOHYDRAZIDE; N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE] 4 FLUOROBENZOHYDRAZIDE; N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE] 4 METHOXYBENZOHYDRAZIDE; N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE] 4 NITROBENZOHYDRAZIDE; N' [(2 CHLOROQUINOLIN 3 YL)METHYLIDENE]BENZOHYDRAZIDE; UNCLASSIFIED DRUG; ANTICONVULSIVE AGENT; CHLORINE DERIVATIVE; QUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG SCREENING; DRUG SYNTHESIS; EPILEPSY; HYDROGEN BOND; IN VIVO STUDY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; ANIMAL; SYNTHESIS; TOXICITY;

ANIMALS; ANTICONVULSANTS; CHLORINE COMPOUNDS; HYDRAZONES; MALE; MICE; QUINOLINES;

EID: 77956370311     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Malawska B.: Curr. Topics Med. Chem. 5, 69 (2005).
2. Shindikar A.V., Khan F., Viswanathan C.L.: Eur. J. Med. Chem. 41, 786 (2006).
3. Bell G.S., Sander J.W.: Seizure 11 (Suppl. A.) 306 (2002).
4. Agarwal N.: J. Pharm. Pharmaceut. Sci. 7, 260 (2004).
5. Popp F.D.: Eur. J. Med. Chem. 24, 313 (1989).
6. Ragavendran J.V., Sriram D., Patel S.K., Reddy I.V., Bharathwajan N., Stables J., Yogeeswari P.: Eur. J. Med. Chem. 42, 146 (2007).
7. Dimmock J.R., Vashishthaa S.C., Stables J.P.: Eur. J. Med. Chem. 35, 241 (2000).
8. Sridhar S.K., Pandeya S.N., Stables J.P., Ramesh A.: Eur. J. Pharm. Sci. 16, 129 (2002).
9. Dimmock J.R., Pandeya S.N., Stables J.P., Quail J.W., Pugazhenthi U. et al.: Eur. J. Med. Chem. 30, 303 (1995).
10. Dimmock J.R., Vashishthaa S.C., Stables J.P.: Pharmazie 50, 823 (1995).
11. Pandeya S.N., Agarwal A.K., Singh A., Stables J.P.: Acta Pharm. 53, 15 (2003).
12. Guan L-P., Jin Q-H., Tian G-R. Chai K-Y., Quan Z-S.: J. Pharm. Pharmaceut. Sci. 10, 254 (2007).
13. Muruganantham N., Sivakumar R., Anbalagan N., Gunasekaran V., Leonard J.T.: Biol. Pharm. Bull. 27, 1683 (2004).
14. Bawa S., Kumar S.: Indian J. Chem. 48B, 142 (2009).
15. Meth-Cohn O., Narine B., Tarnowski B.: J. Chem. Soc. Perkin Trans. I 1520 (1981).
16. th edn., pp. 1007 and 1269, Addison-Wesley Longman Inc., UK 2006.
17. Krall R.I., Penry J.K., White B.G., Kupferberg H.J., Swinyard E.A.: Epilepsia 19, 409 (1978).
18. Loscher W., Schmidt D.: Epilepsy Res. 17, 95 (1994).
19. Dunham N.W., Miya T.A.: J. Am. Pharm. Assoc. Sci. Ed. 46, 208 (1957).